| Stage | ABNB | % of rev | ROL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.6B | 100.00% | $1.1B | 100.00% | ABNB ×3.31 |
| Gross profit | $3.0B | 82.46% | $1.1B | 100.00% | ROL +17.5pp |
| Operating income | $758M | 21.01% | $223M | 20.45% | ABNB +0.6pp |
| Pre-tax income | $897M | 24.86% | $213M | 19.51% | ABNB +5.4pp |
| Net income | $816M | 22.62% | $158M | 14.49% | ABNB +8.1pp |
| Stage | ABNB | ROL | Gap · A − B |
|---|---|---|---|
| Revenue | $3.6B100.00% | $1.1B100.00% | ABNB ×3.31 |
| Gross profit | 82.46%$3.0B | 100.00%$1.1B | ROL +17.5pp |
| Operating income | 21.01%$758M | 20.45%$223M | ABNB +0.6pp |
| Pre-tax income | 24.86%$897M | 19.51%$213M | ABNB +5.4pp |
| Net income |
| 22.62%$816M |
| 14.49%$158M |
| ABNB +8.1pp |
No disclosed counterparties: ABNB, ROL.